• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novartis Ag ADR (NY: NVS )

    107.08 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Novartis Ag ADR

    < Previous 1 2
    ...
    22 23 24 25 26 27 28 29 30
    ...
    42 43 Next >
    Antifungal Drugs Market Import-Export Details, Production Information 2022-2029 : Sanofi-Aventis, Novartis, Pfizer Inc, Abbott Laboratories
    Global Antifungal Drugs Market Research 2022-2031 published by Calibre Research studies the current situation, Antifungal Drugs market size, share, trends, regional growth and the latest technologies... 
    Via SBWire
    Topics Supply Chain
    Exposures Supply Chain
    Celldex Therapeutics Skids As It Takes On A Blockbuster Roche, Novartis Drug
    The study was in 26 patients with chronic hives that don't respond to antihistamines. 
    Via Investor's Business Daily
    Cough Remedies Market 2022-2029 Global Industry Trends, Growth Rate and Revenue : Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis
    Global Cough Remedies Market Research 2022-2031 published by Calibre Research studies the current situation, Cough Remedies market size, share, trends, regional growth and the latest technologies... 
    Via SBWire
    Topics Supply Chain
    Exposures Supply Chain
    The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Novartis Resumes Production, Delivery Of Radioligand Therapy Medicines
    Via Benzinga
    Novartis' Tislelizumab Extends Overall Survival In Late-Stage Esophageal Cancer Study
    Novartis AG (NYSE: NVS) announced results from the Phase 3 RATIONALE 306 trial of tislelizumab plus chemotherapy in patients with unresectable, locally advanced recurrent or metastatic esophageal... 
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    Tigecycline Market Development Factors 2022-2029 Pfizer, Hisun Pharma, Hansoh Pharma, HICIN Pharma, Amgen
    Global Tigecycline Market Research 2022-2031 published by Calibre Research studies the current situation, Tigecycline market size, share, trends, regional growth and the latest technologies utilized by... 
    Via SBWire
    Topics Supply Chain
    Exposures Supply Chain
    Novartis Announces $250M In R&D Funding For Neglected Tropical Diseases, Malaria
    Via Benzinga
    FDA Gives Approval For Novartis' Tafinlar + Mekinist Broadens BRAF/MEK Cancer Combo Use
    Via Benzinga
    Why Precision BioSciences Shares Are Surging Today
    Via Benzinga
    Global Interferon Beta Drugs Market | Key Players are Biogen, Merck, Novartis, Bayer, Faron Pharmaceuticals, and other prominent players
    Global Interferon Beta Drugs Market | Key Players are Biogen, Merck, Novartis, Bayer, Faron Pharmaceuticals, and other prominent players The market size of the Global Interferon Beta Drugs Market in... 
    Via iCrowdNewswire
    Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis International AG and many more.
    Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis... 
    Via iCrowdNewswire
    Precision BioSciences (DTIL) Stock Treks Higher on Novartis Deal
    DTIL stock is advancing in early trading today after Precision BioScience announced a partnership with Novartis, a leading drug maker. 
    Via InvestorPlace
    The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    NYSE:NVS Investor Alert: Investigation over Possible Securities Laws Violations by Novartis AG
    San Diego, CA -- (SBWIRE) -- 06/17/2022 -- Novartis AG is under investigation concerning potential securities laws violations in connection with certain financial statements. 
    Via SBWire
    Analysts Remain Bullish Despite Caribou's Allogeneic CAR-T Hit By Durability
    Via Benzinga
    Crews Control Names Barbara Kittridge President, Andrea Keating Moves to CEO
    Crews Control promotes Barbara Kittridge to President. 
    Via Newswire.com
    Exposures COVID-19
    Sylvester Feddes joins the 2022 Leading Entrepreneurs of the World Conference
    The Country President of Novartis Colombia will speak at 1BusinessWorld’s Leading Entrepreneurs of the World Conference about leading diversity and inclusion in a virtual environment 
    Via News Direct
    Pfizer's Ibrance Fails To Extend Overall Survival In Newly Diagnosed Breast Cancer Setting
    Via Benzinga
    2021 R&D Spending and Intensity Benchmarks
    VIRGINIA BEACH, Va. - June 6, 2022 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D... 
    Via PRLog
    Topics Supply Chain
    Exposures Supply Chain
    NOVARTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Novartis AG on Behalf of Novartis Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    New effort to standardize cardiovascular care in Mexico, address gaps in care
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    NOVARTIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Novartis AG on Behalf of Novartis Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Novartis AG (NVS) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Novartis AG (NVS) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Novartis AG (NVS) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
    May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... 
    Via Benzinga
    Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
    Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,... 
    Via FinancialNewsMedia
    Exposures COVID-19
    6 Dividend Stocks With High Yields and Low P/E Ratios
    These 6 dividend stocks have yields greater than 2.5% and P/E ratios lower than 16x with a positive earnings growth forecast for 2023. 
    Via InvestorPlace
    < Previous 1 2
    ...
    22 23 24 25 26 27 28 29 30
    ...
    42 43 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.